Selected research
Industry Research
Furosemide Injection Industry Research Report 2026
Market perspective
The global Furosemide Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Furosemide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Furosemide Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Furosemide Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Furosemide Injection include AuroMedics, Avet Pharmaceuticals, SteriMax, Baxter, Chengdu Brilliant Pharmaceutical, Fresenius Kabi, Hainan Huanglong Pharm, Hunan Kelun Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Furosemide Injection market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Furosemide Injection Market by Company
AuroMedics
Avet Pharmaceuticals
SteriMax
Baxter
Chengdu Brilliant Pharmaceutical
Fresenius Kabi
Hainan Huanglong Pharm
Hunan Kelun Pharmaceutical
Pfizer
Shagnhai Harvest Pharamceutical
Shenyang Guagnda Pharm
CSPC Ouyi Pharm
Changbaishan Pharmaceutical
Furosemide Injection Segment by Type
40mg/40ml
20mg/2ml
100mg/10ml
Furosemide Injection Segment by Application
Recovery Center
Hospital
Clinics
Furosemide Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furosemide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Furosemide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furosemide Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Furosemide Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Furosemide Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Furosemide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 40mg/40ml
- 20mg/2ml
- 100mg/10ml
Applications
- Recovery Center
- Hospital
- Clinics
Companies covered
- AuroMedics
- Avet Pharmaceuticals
- SteriMax
- Baxter
- Chengdu Brilliant Pharmaceutical
- Fresenius Kabi
- Hainan Huanglong Pharm
- Hunan Kelun Pharmaceutical
- Pfizer
- Shagnhai Harvest Pharamceutical
- Shenyang Guagnda Pharm
- CSPC Ouyi Pharm
- Changbaishan Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Furosemide Injection Market Size (2021-2032)
- 2.2.2 Global Furosemide Injection Sales (2021-2032)
- 2.2.3 Global Furosemide Injection Market Average Price (2021-2032)
- 2.3 Furosemide Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 40mg/40ml
- 2.3.3 20mg/2ml
- 2.3.4 100mg/10ml
- 2.4 Furosemide Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Recovery Center
- 2.4.3 Hospital
- 2.4.4 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Furosemide Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Furosemide Injection Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Furosemide Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Furosemide Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Furosemide Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Furosemide Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Furosemide Injection, Product Type & Application
- 3.8 Global Manufacturers of Furosemide Injection, Established Date
- 3.9 Global Furosemide Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AuroMedics
- 4.1.1 AuroMedics Company Information
- 4.1.2 AuroMedics Business Overview
- 4.1.3 AuroMedics Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AuroMedics Furosemide Injection Product Portfolio
- 4.1.5 AuroMedics Recent Developments
- 4.2 Avet Pharmaceuticals
- 4.2.1 Avet Pharmaceuticals Company Information
- 4.2.2 Avet Pharmaceuticals Business Overview
- 4.2.3 Avet Pharmaceuticals Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Avet Pharmaceuticals Furosemide Injection Product Portfolio
- 4.2.5 Avet Pharmaceuticals Recent Developments
- 4.3 SteriMax
- 4.3.1 SteriMax Company Information
- 4.3.2 SteriMax Business Overview
- 4.3.3 SteriMax Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SteriMax Furosemide Injection Product Portfolio
- 4.3.5 SteriMax Recent Developments
- 4.4 Baxter
- 4.4.1 Baxter Company Information
- 4.4.2 Baxter Business Overview
- 4.4.3 Baxter Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Baxter Furosemide Injection Product Portfolio
- 4.4.5 Baxter Recent Developments
- 4.5 Chengdu Brilliant Pharmaceutical
- 4.5.1 Chengdu Brilliant Pharmaceutical Company Information
- 4.5.2 Chengdu Brilliant Pharmaceutical Business Overview
- 4.5.3 Chengdu Brilliant Pharmaceutical Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Chengdu Brilliant Pharmaceutical Furosemide Injection Product Portfolio
- 4.5.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 4.6 Fresenius Kabi
- 4.6.1 Fresenius Kabi Company Information
- 4.6.2 Fresenius Kabi Business Overview
- 4.6.3 Fresenius Kabi Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fresenius Kabi Furosemide Injection Product Portfolio
- 4.6.5 Fresenius Kabi Recent Developments
- 4.7 Hainan Huanglong Pharm
- 4.7.1 Hainan Huanglong Pharm Company Information
- 4.7.2 Hainan Huanglong Pharm Business Overview
- 4.7.3 Hainan Huanglong Pharm Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hainan Huanglong Pharm Furosemide Injection Product Portfolio
- 4.7.5 Hainan Huanglong Pharm Recent Developments
- 4.8 Hunan Kelun Pharmaceutical
- 4.8.1 Hunan Kelun Pharmaceutical Company Information
- 4.8.2 Hunan Kelun Pharmaceutical Business Overview
- 4.8.3 Hunan Kelun Pharmaceutical Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hunan Kelun Pharmaceutical Furosemide Injection Product Portfolio
- 4.8.5 Hunan Kelun Pharmaceutical Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Furosemide Injection Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 Shagnhai Harvest Pharamceutical
- 4.10.1 Shagnhai Harvest Pharamceutical Company Information
- 4.10.2 Shagnhai Harvest Pharamceutical Business Overview
- 4.10.3 Shagnhai Harvest Pharamceutical Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shagnhai Harvest Pharamceutical Furosemide Injection Product Portfolio
- 4.10.5 Shagnhai Harvest Pharamceutical Recent Developments
- 4.11 Shenyang Guagnda Pharm
- 4.11.1 Shenyang Guagnda Pharm Company Information
- 4.11.2 Shenyang Guagnda Pharm Business Overview
- 4.11.3 Shenyang Guagnda Pharm Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shenyang Guagnda Pharm Furosemide Injection Product Portfolio
- 4.11.5 Shenyang Guagnda Pharm Recent Developments
- 4.12 CSPC Ouyi Pharm
- 4.12.1 CSPC Ouyi Pharm Company Information
- 4.12.2 CSPC Ouyi Pharm Business Overview
- 4.12.3 CSPC Ouyi Pharm Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CSPC Ouyi Pharm Furosemide Injection Product Portfolio
- 4.12.5 CSPC Ouyi Pharm Recent Developments
- 4.13 Changbaishan Pharmaceutical
- 4.13.1 Changbaishan Pharmaceutical Company Information
- 4.13.2 Changbaishan Pharmaceutical Business Overview
- 4.13.3 Changbaishan Pharmaceutical Furosemide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Changbaishan Pharmaceutical Furosemide Injection Product Portfolio
- 4.13.5 Changbaishan Pharmaceutical Recent Developments
5 Global Furosemide Injection Market Scenario by Region
- 5.1 Global Furosemide Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Furosemide Injection Sales by Region: 2021-2032
- 5.2.1 Global Furosemide Injection Sales by Region: 2021-2026
- 5.2.2 Global Furosemide Injection Sales by Region: 2027-2032
- 5.3 Global Furosemide Injection Revenue by Region: 2021-2032
- 5.3.1 Global Furosemide Injection Revenue by Region: 2021-2026
- 5.3.2 Global Furosemide Injection Revenue by Region: 2027-2032
- 5.4 North America Furosemide Injection Market Facts & Figures by Country
- 5.4.1 North America Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Furosemide Injection Sales by Country (2021-2032)
- 5.4.3 North America Furosemide Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Furosemide Injection Market Facts & Figures by Country
- 5.5.1 Europe Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Furosemide Injection Sales by Country (2021-2032)
- 5.5.3 Europe Furosemide Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Furosemide Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Furosemide Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Furosemide Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Furosemide Injection Market Facts & Figures by Country
- 5.7.1 South America Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Furosemide Injection Sales by Country (2021-2032)
- 5.7.3 South America Furosemide Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Furosemide Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Furosemide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Furosemide Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Furosemide Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Furosemide Injection Sales by Type (2021-2032)
- 6.1.1 Global Furosemide Injection Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Furosemide Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Furosemide Injection Revenue by Type (2021-2032)
- 6.2.1 Global Furosemide Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Furosemide Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Furosemide Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Furosemide Injection Sales by Application (2021-2032)
- 7.1.1 Global Furosemide Injection Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Furosemide Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Furosemide Injection Revenue by Application (2021-2032)
- 7.2.1 Global Furosemide Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Furosemide Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Furosemide Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Furosemide Injection Value Chain Analysis
- 8.1.1 Furosemide Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Furosemide Injection Production Mode & Process
- 8.2 Furosemide Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Furosemide Injection Distributors
- 8.2.3 Furosemide Injection Customers
9 Global Furosemide Injection Analyzing Market Dynamics
- 9.1 Furosemide Injection Industry Trends
- 9.2 Furosemide Injection Industry Drivers
- 9.3 Furosemide Injection Industry Opportunities and Challenges
- 9.4 Furosemide Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst